Consulting Services
Compare Stocks
5 / 10Stock Comparison
EXPO vs ICFI vs CRAI vs HCI vs FORR
Revenue, margins, valuation, and 5-year total return — side by side.
Consulting Services
Consulting Services
Insurance - Property & Casualty
Consulting Services
EXPO vs ICFI vs CRAI vs HCI vs FORR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Consulting Services | Consulting Services | Consulting Services | Insurance - Property & Casualty | Consulting Services |
| Market Cap | $3.12B | $1.35B | $899M | $1.99B | $125M |
| Revenue (TTM) | $582M | $1.82B | $771M | $927M | $397M |
| Net Income (TTM) | $106M | $85M | $48M | $314M | $-119M |
| Gross Margin | 40.1% | 27.2% | 20.3% | 66.5% | 64.6% |
| Operating Margin | 20.6% | 7.9% | 9.8% | 47.9% | -20.9% |
| Forward P/E | 30.9x | 10.6x | 16.9x | 9.2x | 8.5x |
| Total Debt | $83M | $571M | $127M | $68M | $72M |
| Cash & Equiv. | $222M | $5M | $18M | $1.21B | $63M |
EXPO vs ICFI vs CRAI vs HCI vs FORR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Exponent, Inc. (EXPO) | 100 | 85.5 | -14.5% |
| ICF International, … (ICFI) | 100 | 113.6 | +13.6% |
| CRA International, … (CRAI) | 100 | 344.4 | +244.4% |
| HCI Group, Inc. (HCI) | 100 | 340.8 | +240.8% |
| Forrester Research,… (FORR) | 100 | 20.8 | -79.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: EXPO vs ICFI vs CRAI vs HCI vs FORR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
EXPO is the #2 pick in this set and the best alternative if income & stability is your priority.
- Dividend streak 13 yrs, beta 0.89, yield 1.9%
- 1.9% yield, 13-year raise streak, vs CRAI's 1.5%, (1 stock pays no dividend)
- 13.7% ROA vs FORR's -28.2%, ROIC 36.3% vs 0.8%
ICFI plays a supporting role in this comparison — it may shine differently against other peers.
CRAI is the clearest fit if your priority is long-term compounding.
- 5.5% 10Y total return vs HCI's 436.8%
HCI carries the broadest edge in this set and is the clearest fit for growth exposure and sleep-well-at-night.
- Rev growth 20.2%, EPS growth 179.8%, 3Y rev CAGR 22.3%
- Lower volatility, beta 0.39, Low D/E 6.1%, current ratio 1.24x
- PEG 0.19 vs EXPO's 5.18
- Beta 0.39, yield 1.0%, current ratio 1.24x
Among these 5 stocks, FORR doesn't own a clear edge in any measured category.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 20.2% revenue growth vs FORR's -8.2% | |
| Value | Lower P/E (9.2x vs 16.9x), PEG 0.19 vs 0.78 | |
| Quality / Margins | 33.9% margin vs FORR's -30.1% | |
| Stability / Safety | Beta 0.39 vs EXPO's 0.89, lower leverage | |
| Dividends | 1.9% yield, 13-year raise streak, vs CRAI's 1.5%, (1 stock pays no dividend) | |
| Momentum (1Y) | +2.4% vs FORR's -35.7% | |
| Efficiency (ROA) | 13.7% ROA vs FORR's -28.2%, ROIC 36.3% vs 0.8% |
EXPO vs ICFI vs CRAI vs HCI vs FORR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
EXPO vs ICFI vs CRAI vs HCI vs FORR — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
HCI leads in 3 of 6 categories
FORR leads 1 • EXPO leads 1 • ICFI leads 0 • CRAI leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
HCI leads this category, winning 6 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ICFI is the larger business by revenue, generating $1.8B annually — 4.6x FORR's $397M. HCI is the more profitable business, keeping 33.9% of every revenue dollar as net income compared to FORR's -30.1%. On growth, HCI holds the edge at +11.9% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $582M | $1.8B | $771M | $927M | $397M |
| EBITDAEarnings before interest/tax | $125M | $201M | $98M | $454M | -$66M |
| Net IncomeAfter-tax profit | $106M | $85M | $48M | $314M | -$119M |
| Free Cash FlowCash after capex | $122M | $151M | -$17M | $431M | $18M |
| Gross MarginGross profit ÷ Revenue | +40.1% | +27.2% | +20.3% | +66.5% | +64.6% |
| Operating MarginEBIT ÷ Revenue | +20.6% | +7.9% | +9.8% | +47.9% | -20.9% |
| Net MarginNet income ÷ Revenue | +18.2% | +4.7% | +6.2% | +33.9% | -30.1% |
| FCF MarginFCF ÷ Revenue | +21.0% | +8.3% | -2.2% | +46.4% | +4.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +7.8% | -10.3% | +10.5% | +11.9% | -6.5% |
| EPS Growth (YoY)Latest quarter vs prior year | +6.5% | -22.2% | -35.5% | +23.4% | -79.1% |
Valuation Metrics
FORR leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 6.1x trailing earnings, HCI trades at a 80% valuation discount to EXPO's 30.6x P/E. Adjusting for growth (PEG ratio), HCI offers better value at 0.13x vs EXPO's 5.15x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $3.1B | $1.3B | $899M | $2.0B | $125M |
| Enterprise ValueMkt cap + debt − cash | $3.0B | $1.9B | $1.0B | $844M | $134M |
| Trailing P/EPrice ÷ TTM EPS | 30.65x | 15.05x | 17.09x | 6.15x | -1.04x |
| Forward P/EPrice ÷ next-FY EPS est. | 30.87x | 10.60x | 16.88x | 9.19x | 8.54x |
| PEG RatioP/E ÷ EPS growth rate | 5.15x | 1.31x | 0.79x | 0.13x | — |
| EV / EBITDAEnterprise value multiple | 22.99x | 9.13x | 10.36x | 1.92x | 8.00x |
| Price / SalesMarket cap ÷ Revenue | 5.37x | 0.72x | 1.20x | 2.20x | 0.32x |
| Price / BookPrice ÷ Book value/share | 8.33x | 1.33x | 4.37x | 1.77x | 0.98x |
| Price / FCFMarket cap ÷ FCF | 25.54x | 11.22x | 48.45x | 4.47x | 6.92x |
Profitability & Efficiency
HCI leads this category, winning 8 of 9 comparable metrics.
Profitability & Efficiency
HCI delivers a 32.0% return on equity — every $100 of shareholder capital generates $32 in annual profit, vs $-81 for FORR. HCI carries lower financial leverage with a 0.06x debt-to-equity ratio, signaling a more conservative balance sheet compared to CRAI's 0.60x. On the Piotroski fundamental quality scale (0–9), HCI scores 8/9 vs FORR's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +25.5% | +8.3% | +23.6% | +32.0% | -80.8% |
| ROA (TTM)Return on assets | +13.7% | +4.1% | +7.6% | +13.2% | -28.2% |
| ROICReturn on invested capital | +36.3% | +7.2% | +20.4% | +6.8% | +0.8% |
| ROCEReturn on capital employed | +19.2% | +9.3% | +26.9% | +40.6% | +0.8% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 6 | 4 | 8 | 4 |
| Debt / EquityFinancial leverage | 0.21x | 0.56x | 0.60x | 0.06x | 0.57x |
| Net DebtTotal debt minus cash | -$139M | $566M | $109M | -$1.1B | $9M |
| Cash & Equiv.Liquid assets | $222M | $5M | $18M | $1.2B | $63M |
| Total DebtShort + long-term debt | $83M | $571M | $127M | $68M | $72M |
| Interest CoverageEBIT ÷ Interest expense | — | 6.75x | 14.51x | 67.24x | -30.30x |
Total Returns (Dividends Reinvested)
HCI leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in HCI five years ago would be worth $20,530 today (with dividends reinvested), compared to $1,413 for FORR. Over the past 12 months, HCI leads with a +2.4% total return vs FORR's -35.7%. The 3-year compound annual growth rate (CAGR) favors HCI at 45.7% vs FORR's -36.6% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -9.1% | -12.5% | -30.3% | -16.7% | -19.9% |
| 1-Year ReturnPast 12 months | -13.6% | -11.0% | -20.7% | +2.4% | -35.7% |
| 3-Year ReturnCumulative with dividends | -24.4% | -32.1% | +54.1% | +209.6% | -74.5% |
| 5-Year ReturnCumulative with dividends | -28.5% | -16.9% | +71.5% | +105.3% | -85.9% |
| 10-Year ReturnCumulative with dividends | +186.1% | +100.5% | +550.5% | +436.8% | -75.9% |
| CAGR (3Y)Annualised 3-year return | -8.9% | -12.1% | +15.5% | +45.7% | -36.6% |
Risk & Volatility
Evenly matched — EXPO and HCI each lead in 1 of 2 comparable metrics.
Risk & Volatility
HCI is the less volatile stock with a 0.39 beta — it tends to amplify market swings less than EXPO's 0.89 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. EXPO currently trades 77.4% from its 52-week high vs FORR's 56.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.89x | 0.52x | 0.73x | 0.39x | 0.68x |
| 52-Week HighHighest price in past year | $81.95 | $101.71 | $227.29 | $210.50 | $11.57 |
| 52-Week LowLowest price in past year | $63.25 | $64.52 | $135.95 | $136.37 | $4.88 |
| % of 52W HighCurrent price vs 52-week peak | +77.4% | +73.2% | +61.2% | +72.6% | +56.4% |
| RSI (14)Momentum oscillator 0–100 | 38.6 | 59.8 | 41.1 | 48.7 | 51.6 |
| Avg Volume (50D)Average daily shares traded | 452K | 349K | 187K | 167K | 109K |
Analyst Outlook
EXPO leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: EXPO as "Buy", ICFI as "Buy", CRAI as "Buy", HCI as "Buy", FORR as "Hold". Consensus price targets imply 39.4% upside for CRAI (target: $194) vs -17.2% for HCI (target: $127). For income investors, EXPO offers the higher dividend yield at 1.89% vs ICFI's 0.75%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | $85.00 | $102.50 | $194.00 | $126.50 | — |
| # AnalystsCovering analysts | 8 | 13 | 1 | 14 | 4 |
| Dividend YieldAnnual dividend ÷ price | +1.9% | +0.8% | +1.5% | +1.0% | — |
| Dividend StreakConsecutive years of raises | 13 | 8 | 9 | 2 | 6 |
| Dividend / ShareAnnual DPS | $1.20 | $0.56 | $2.06 | $1.50 | — |
| Buyback YieldShare repurchases ÷ mkt cap | +3.1% | +4.1% | +5.2% | +0.1% | +2.0% |
HCI leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). FORR leads in 1 (Valuation Metrics). 1 tied.
EXPO vs ICFI vs CRAI vs HCI vs FORR: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is EXPO or ICFI or CRAI or HCI or FORR a better buy right now?
For growth investors, HCI Group, Inc.
(HCI) is the stronger pick with 20. 2% revenue growth year-over-year, versus -8. 2% for Forrester Research, Inc. (FORR). HCI Group, Inc. (HCI) offers the better valuation at 6. 1x trailing P/E (9. 2x forward), making it the more compelling value choice. Analysts rate Exponent, Inc. (EXPO) a "Buy" — based on 8 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — EXPO or ICFI or CRAI or HCI or FORR?
On trailing P/E, HCI Group, Inc.
(HCI) is the cheapest at 6. 1x versus Exponent, Inc. at 30. 6x. On forward P/E, Forrester Research, Inc. is actually cheaper at 8. 5x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: HCI Group, Inc. wins at 0. 19x versus Exponent, Inc. 's 5. 18x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — EXPO or ICFI or CRAI or HCI or FORR?
Over the past 5 years, HCI Group, Inc.
(HCI) delivered a total return of +105. 3%, compared to -85. 9% for Forrester Research, Inc. (FORR). Over 10 years, the gap is even starker: CRAI returned +550. 5% versus FORR's -75. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — EXPO or ICFI or CRAI or HCI or FORR?
By beta (market sensitivity over 5 years), HCI Group, Inc.
(HCI) is the lower-risk stock at 0. 39β versus Exponent, Inc. 's 0. 89β — meaning EXPO is approximately 127% more volatile than HCI relative to the S&P 500. On balance sheet safety, HCI Group, Inc. (HCI) carries a lower debt/equity ratio of 6% versus 60% for CRA International, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — EXPO or ICFI or CRAI or HCI or FORR?
By revenue growth (latest reported year), HCI Group, Inc.
(HCI) is pulling ahead at 20. 2% versus -8. 2% for Forrester Research, Inc. (FORR). On earnings-per-share growth, the picture is similar: HCI Group, Inc. grew EPS 179. 8% year-over-year, compared to -1993. 3% for Forrester Research, Inc.. Over a 3-year CAGR, HCI leads at 22. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — EXPO or ICFI or CRAI or HCI or FORR?
HCI Group, Inc.
(HCI) is the more profitable company, earning 33. 2% net margin versus -30. 1% for Forrester Research, Inc. — meaning it keeps 33. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HCI leads at 47. 7% versus 0. 5% for FORR. At the gross margin level — before operating expenses — HCI leads at 73. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is EXPO or ICFI or CRAI or HCI or FORR more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, HCI Group, Inc. (HCI) is the more undervalued stock at a PEG of 0. 19x versus Exponent, Inc. 's 5. 18x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Forrester Research, Inc. (FORR) trades at 8. 5x forward P/E versus 30. 9x for Exponent, Inc. — 22. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CRAI: 39. 4% to $194. 00.
08Which pays a better dividend — EXPO or ICFI or CRAI or HCI or FORR?
In this comparison, EXPO (1.
9% yield), CRAI (1. 5% yield), HCI (1. 0% yield), ICFI (0. 8% yield) pay a dividend. FORR does not pay a meaningful dividend and should not be held primarily for income.
09Is EXPO or ICFI or CRAI or HCI or FORR better for a retirement portfolio?
For long-horizon retirement investors, HCI Group, Inc.
(HCI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 39), 1. 0% yield, +436. 8% 10Y return). Both have compounded well over 10 years (HCI: +436. 8%, FORR: -75. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between EXPO and ICFI and CRAI and HCI and FORR?
These companies operate in different sectors (EXPO (Industrials) and ICFI (Industrials) and CRAI (Industrials) and HCI (Financial Services) and FORR (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: EXPO is a small-cap quality compounder stock; ICFI is a small-cap deep-value stock; CRAI is a small-cap deep-value stock; HCI is a small-cap high-growth stock; FORR is a small-cap quality compounder stock. EXPO, ICFI, CRAI, HCI pay a dividend while FORR does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.